Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02736812Phase 3Completed
A Phase 3 trial of French lyophilized plasma in hemorrhagic shock, trauma-induced coagulopathy (TIC), sponsored by French Defence Health Service. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02736812.